Tausight

Tausight builds what it calls a situational PHI awareness platform: AI-driven discovery and continuous monitoring of protected health information as it moves across a healthcare organization’s decentralized mix of EHR systems, endpoints, mobile devices, cloud applications, and third-party vendors. Healthcare data protection is a structurally harder problem than generic DLP because PHI proliferates across clinical workflows, medical devices, and partner systems in ways general-purpose data classification tools weren’t built to track, and because a breach carries both HIPAA liability and direct patient-safety implications.

Founded in 2018 by David Ting, the former CTO and co-founder of healthcare identity vendor Imprivata, and led by Frank Nydam, Tausight is based in Boston, Massachusetts. The company has raised roughly $31 million across a $20 million Series A (2022) and a $6 million follow-on round in 2023 led by Polaris Partners with participation from Flare Capital Partners and .406 Ventures — a syndicate with deep healthcare-technology focus. Tausight has announced technology integrations with CrowdStrike (February 2024) and a partnership with Dell Technologies, both aimed at extending PHI risk visibility into existing endpoint security and infrastructure investments healthcare IT teams already run.

Tausight’s founder pedigree and healthcare-specialist investor base are real credibility signals in a sector where generic security vendors often struggle to earn trust from hospital IT and compliance teams. The company’s efficacy claims, however, rest primarily on its own published customer materials and industry-outlet recognition rather than independently audited breach-prevention outcomes, which is typical for a company at this stage but worth factoring into any procurement evaluation.